|
AU7085400A
|
|
Compositions of immunostimulatory polymers and saponin adjuvants and uses thereof
|
|
WO0009159A1
|
|
Compositions of cpg and saponin adjuvants and methods thereof
|
|
AU1197799A
|
|
Granulocytic ehrlichia genes and uses thereof
|
|
WO9910008A1
|
|
Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
|
|
EP0988053A1
|
|
Purified saponins as oral adjuvants
|
|
WO9849313A2
|
|
Characterization of granulocytic ehrlichia and methods of use
|
|
US6306394B1
|
|
Nucleic acids, proteins, and methods of use of granulocytic ehrlichia
|
|
US6231859B1
|
|
Saponin adjuvant compositions
|
|
CA2273922A1
|
|
Novel saponin compositions and uses thereof
|
|
US5976860A
|
|
Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
|
|
US6284238B1
|
|
Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
|
|
US6228608B1
|
|
Recombinant FIV glycoprotein 160 and P24 gag protein
|
